The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice

Low dose naltrexone in the treatment of dissociative symptoms (article in German)

Nervenarzt
March 2015
https://pubmed.ncbi.nlm.nih.gov/25421416/

Background: Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day).

Galyn Forster, MS, LP - Treating Psychiatric Disorders with LDN Case Studies (2019 Conference) (LDN, low dose naltrexone)

Galyn Forster's case studies include: Traumatic stress disorder, dissociative disorder, anxiety, phobia, pain and hypervigilance

Wiebke Pape, MD - A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorder I (2017 Conference) (LDN, low dose naltrexone)

Dr Wiebke Pape shares her presentation on Self-Awareness at The LDN 2017 Conference.

Ulrich Lanius, PhD - Traumatic Stress and Dissociative Symptoms (2017 Conference) (LDN, low dose naltrexone)

Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.